Drug
AT 301b
AT 301b: highest development phase Phase 1, developed by Atossa Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Atossa Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AT-301B NCT04519788 | Phase 1 | Healthy |
Latest
No recent events.
Follow AT 301b on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.